Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference
Provided By GlobeNewswire
Last update: Jan 29, 2025
SAN FRANCISCO and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025 at 1:00 p.m. E.T.
Read more at globenewswire.com
